---
slug: cerebrolysin
title: "cerebrolysin"
kind: standard
status: published
hash: aa10948330f1839b59d9723072e2ac3937be686b86651a9529e278eb0471ac1f
created: 2026-06-29T16:54:15.000Z
updated: 2026-10-08T11:49:55.081Z
summary: "Evidence is being populated by Grok web"
tags: []
above: []
below: []
adjacent: []
nested: []
---
# cerebrolysin

*Evidence is being populated by Grok web*

## Overview
Evidence is being populated by Grok web search.

## Facts

```json
{
  "converted_from": "markdown",
  "original_updated": "2026-06-29T16:54:15.944Z",
  "register": "standard",
  "category": null
}
```

## Sources

1. [The possible role of cerebrolysin in the management of vascular dementia: Leveraging concepts](https://pubmed.ncbi.nlm.nih.gov/39832667/) — “CBL could be effective therapeutic strategy in preventing and treating VD by targeting neuroinflammation, BBB injury, and chronic cerebral hypoperfusion.” (sha256 7fd30112042c00b3)
2. [Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study](https://pubmed.ncbi.nlm.nih.gov/39957612/) — “Cerebrolysin combined with speech and language therapy offers promising potential for enhancing recovery in poststroke nonfluent aphasia.” (sha256 4235f3a24d2e893c)
3. [Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia After Stroke](https://clinicaltrials.gov/study/NCT06897176) — “This study aims to measure changes in language ability after adding cerebrolysin to standard treatment for non-fluent aphasia patients with post-stroke ...” (sha256 7b809802a425051e)
4. [Cerebrolysin in Critically Ill Patients With Delirium](https://clinicaltrials.gov/study/NCT06677502) — “Cerebrolysin, 50 mL daily administered intravenously for seven consecutive days, reduces or alleviates the severity of delirium detected by the CAM-ICU test.” (sha256 e04d24084d8308b1)
5. [Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke](https://pubmed.ncbi.nlm.nih.gov/41018475/) — “These findings suggest that Cerebrolysin significantly enhances early neurological recovery after ischemic stroke, with a comparable safety profile.” (sha256 8f4ae865b3fb5b84)
6. [C-REGS2-A multinational, high-quality comparative ...](https://pubmed.ncbi.nlm.nih.gov/40851188/) — “The results of the C-REGS2 study showed the effectiveness and safety of Cerebrolysin treatment for moderate acute IS in real-world clinical practice.” (sha256 8f071aac99caea46)